Metraipolis › archive › dc_2af5aa85bfb1

Innovating shorter, all-oral, precise, individualized treatment regimen for rifampicin-resistant tuberculosis (INSPIRE TB): study protocol for a pragmatic… — Europe PMC PMID:41845289

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41845289
DOI
10.1186/s12879-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-04T08:12:23.010Z
SHA-256 of the archived text
072e680b122cad627e6118bd5a5d857c614200f06e49c0d5427481d35fe48089
Stable URL of this page
https://metraipolis.com/documento/dc_2af5aa85bfb1

How to cite

Innovating shorter, all-oral, precise, individualized treatment regimen for rifampicin-resistant tuberculosis (INSPIRE TB): study protocol for a pragmatic… — Europe PMC PMID:41845289 — Europe PMC (en), https://europepmc.org/article/MED/41845289 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2af5aa85bfb1 (Metraipolis archive dc_2af5aa85bfb1, sha256 072e680b122cad627e6118bd5a5d857c614200f06e49c0d5427481d35fe48089)
BibTeX
@misc{dc2af5aa85bfb1,
  title = {Innovating shorter, all-oral, precise, individualized treatment regimen for rifampicin-resistant tuberculosis (INSPIRE TB): study protocol for a pragmatic… — Europe PMC PMID:41845289},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41845289},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2af5aa85bfb1; sha256 072e680b122cad627e6118bd5a5d857c614200f06e49c0d5427481d35fe48089},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41845289. Agents can read the archived copy with the MCP tool read_document.